Congress finally passed a bill to allow Medicare the right to negotiate the price of certain drugs with pharmaceutical companies. Medicare now has the ability to negotiate prices just like every private insurance company and every foreign government. Through negotiations these drug prices will likely go down, and result in lower premiums for every person receiving health coverage through Medicare – almost every person over the age of 65.
This new law sounds great, except that Sen. Mike Lee has now introduced a bill in Congress to overturn this new law and go back to the system where pharmaceutical companies set the price that they charge Medicare.
Lee says he has to overturn this law because he believes that pharmaceutical companies, which often make hundreds of millions off of the sales of new drugs, will stop developing new drugs. Why would this result occur when pharmaceutical companies have always had to negotiate prices with private insurers and every foreign government?
Does Lee really believe his own claim? Or could there be another reason? When in doubt, a good rule is to “follow the money.” The money in this case that is paid/ donated to Lee by pharmaceutical companies.
If any senior, or for that matter any person had doubts about Mike Lee’s goals in Congress, that question should now be answered. He looks out for himself and his own pocketbook, rather than the people he “represents.”
Seniors: Ask yourselves if you are for or against lowering your health care premiums when you vote this year.
Bob Gilchrist, Millcreek
